Insulet Corp
(MEX:PODD)
MXN
4702.68
0 (0%)
Market Cap: 372.46 Bil
Enterprise Value: 382.28 Bil
PE Ratio: 45.89
PB Ratio: 16.81
GF Score: 87/100 
Insulet Corp at Cowen Healthcare Conference (Virtual) Transcript
Mar 02, 2021 / 02:10PM GMT
Chris Lin
Cowen and Company, LLC, Research Division - VP of Health Care - Life Science and Diagnostic Tools
All right. Good morning, everyone. I'm Chris Lin, one of Cowen's health care analysts. It is my pleasure to welcome Insulet to our conference. From the company, we have Shacey Petrovic, who is President and CEO. We also have Wayde McMillan, who is CFO. So thanks for being here.
Shacey Petrovic
Insulet Corporation - President, CEO & Director
Great to be here, Chris.
Chris Lin
Cowen and Company, LLC, Research Division - VP of Health Care - Life Science and Diagnostic Tools
Great. So just to provide a quick road map, over the next 30 minutes, my goal is to cover 3 key topics including: one, the insulin pump market dynamics; two, Omnipod 5; and three, margin expansion targets. So with that, why don't we just jump into it?
Questions & Answers
Chris Lin
Cowen and Company, LLC, Research Division - VP of Health Care - Life Science and Diagnostic Tools
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers